Twitter
Advertisement

COVID-19: With spike of 45,149 cases, India's coronavirus tally crosses 79 lakh

With 1,41,001 total active cases, Maharashtra continues to be the worst affected state by COVID-19 in the country.

Latest News
article-main
File photo: COVID-19 patients perform yoga organized by Indo-Tibetan Border Police at ITBP-run Sardar Patel COVID Care Centre & Hospital, in New Delhi (ANI Photo)
FacebookTwitterWhatsappLinkedin

With 45,149 new COVID-19 cases, India's total cases surged to 79,09,960 on Monday, according to the Ministry of Health and Family Welfare.

With 480 new deaths, the COVID-19 toll mounted to 1,19,014, as per the Union Health Ministry.

The number of total active COVID-19 cases stood at 6,53,717 after a decrease of 14,437 in the last 24 hours. Total cured cases stand at 71,37,229 with 59,105 new discharges in the last 24 hours.

With 1,41,001 total active cases, Maharashtra continues to be the worst affected state by COVID-19 in the country. While 14,60,755 patients have recovered from the disease in the state, 43,264 have died so far.

Among other severely affected states, Karnataka has 81,069 active cases, while 7,10,843 people have recovered and 10,905 have succumbed to the coronavirus.

Kerala has 96,688 active cases, while 2,94,910 patients have been cured so far in the state along with 1,332 deaths reported due to the disease.

West Bengal has 37,017 active cases, while Tamil Nadu and the national capital Delhi have 30,606 and 26,744 active cases respectively.

Meanwhile, a total of 10,34,62,778 samples tested for COVID-19 up to 25th October. Of these 9,39,309 samples were tested yesterday, according to the Indian Council of Medical Research (ICMR).

In related news, the third phase human trial of indigenously developed COVID-19 vaccine 'Covaxin' will soon commence at the Institute of Medical Sciences (IMS) and SUM Hospital in Odisha.

IMS and SUM Hospital is in the list of 21 medical institutes selected across the country by the Indian Council for Medical Research (ICMR) where the third phase trial would be conducted. It is the only institute in Odisha which has been selected for the trial.

Find your daily dose of news & explainers in your WhatsApp. Stay updated, Stay informed-  Follow DNA on WhatsApp.
Advertisement

Live tv

Advertisement
Advertisement